ABSTRACT
Background Despite the advance of cataract surgery astigmatism still occur after cataract surgery due to several reasons these include the preparation and closure of the surgical wound, the choice of suture material, and both intraoperative and postoperative manipulations in Phacoemulsification and Extracapsular cataract Etraction.
Objectives To evaluate cataract surgery as cause of astigmatisms among patients undergoing phacoemulsification and extracapsular cataract extraction at eye department in KCMC hospital from Sept 2022 to April 2023
Methods It is a clinic-based, prospective cohort study. Keratometric values and demographic data were collected for eligible patients who had undergone phacoemulsification and Extracapsular Cataract Extraction using a non-contact Auto Refkeratometer BARK-80.
Results A total of 215 patients were recruited for the study. There were 129 (60%) females and 86 (40%) males. The mean age was 67.481 (SD 10.79years). A total 110 patients had undergone phacoemulsification and 105 had undergone Extracapsular Cataract Extraction (ECCE). 189 (87.91%), had a magnitude greater or equal (≥) to 0.5 post OP astigmatism. The mean corneal astigmatism among all patients undergone ECCE were 2.29D (SD 1.41 D) and all undergone PHACO were 0.95D (SD 0.79 D). The mean astigmatism among patients who had cataract surgery done by specialist were 1.19D (SD 0.09 D) and 2.41D (SD 0.16 D) were done by residents There was no astigmatism in 7 patients (3.26%), with-the-rule (WTR) in 68 patients (31.63%), against-the-rule (ATR) in 112 patients (52.09%) and oblique astigmatism (OA) in 28 patients (13.02%). The tendency of a gradual change from with the rule (WTR) to against the rule (ATR) astigmatism was noted as the age advanced.
Conclusion The present study reveals the magnitude of astigmatism is higher in patients underwent Extra Capsular Cataract Extraction than Phacoemulsification in eye department at KCMC hospital and pre-existing astigmatism is a cause of surgical induced astigmatism if pre- operative astigmatism correction is not taken into consideration.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no any financial assistance
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Kilimanjaro Christian Medical University College Research and Ethics Review Committee (KCMU CRERC) with clearance number PG 76/2022.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
data is available at KCMUCo for confidentiality
